Lives unaffected by cystic fibrosis

DRUG DEVELOPMENT PIPELINE

Back to the Drug Development Pipeline

PTI-808

Phase Two

Phase Two

Therapeutic Approach

Restore CFTR Function

PTI-808 is a type of CFTR modulator called a potentiator. Potentiators help facilitate the opening of the chloride channel on the cell surface to allow chloride and sodium (salt) to move in and out of the cell.

Status

A phase 1 study to test the safety and tolerability of PTI-808 in healthy adults is underway.

Sponsor

This program is sponsored by Proteostasis Therapeutics. It is being conducted through the Therapeutics Development Network.



Contact us about PTI-808 >